Needham on Boston Scientific (BSX): 'one of the highest quality large-cap med tech companies'
Tweet Send to a Friend
Needham analyst Mike Matson reiterated a Buy rating and $121.00 price target on Boston Scientific (NYSE: BSX).The analyst comments "BSX ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
